Type
. The changing face of leprosy. The British journal of ophthalmology [Internet]. 2006;90(5):528-9. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1857054/pdf/528.pdf
Type
. Psychiatric morbidity among leprosy patients in Teso and Busia districts of Western Kenya. East African medical journal [Internet]. 2005;82(9):452-6. Available from: https://www.ajol.info/index.php/eamj/article/view/9335
Type
. The continuing challenges of leprosy. Clinical microbiology reviews [Internet]. 2006;19(2):338-81. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1471987/pdf/0036-05.pdf
Type
. A ten-year historic study of paranasal cavity endoscopy in patients with Leprosy. Brazilian journal of otorhinolaryngology [Internet]. 2005;71(5):609-15. Available from: http://www.scielo.br/pdf/rboto/v71n5/en_a11v71n5.pdf
Type
. Isothermal amplification and molecular typing of the obligate intracellular pathogen Mycobacterium leprae isolated from tissues of unknown origins. Journal of clinical microbiology [Internet]. 2006;44(4):1502-8. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1448671/pdf/1524-05.pdf
Type
. Synthesis and antileprosy activity of some dialkyldithiocarbamates. The Journal of antimicrobial chemotherapy. 2006;57(6):1134-8.
Type
. DC-SIGN association with the Th2 environment of lepromatous lesions: cause or effect?. The Journal of pathology. 2006;209(2):182-9.
Type
. Anti-neutrophil cytoplasmic antibodies in leprosy. Clinical rheumatology. 2007;26(2):208-10.
Type
. Bactericidal activities of R207910 and other newer antimicrobial agents against Mycobacterium leprae in mice. Antimicrobial agents and chemotherapy. 2006;50(4):1558-60.
Type
. Leprosy in Mexico. Nihon Hansenbyo Gakkai zasshi = Japanese journal of leprosy : official organ of the Japanese Leprosy Association. 2006;75(1):51-8.